Publication
Evaluation of the growth factors VEGF-a and VEGF-B in the vitreous and serum of patients with macular and retinal vascular diseases
dc.contributor.author | Mesquita, Joana | |
dc.contributor.author | Sousa, João Paulo Castro De | |
dc.contributor.author | Pereira, Sara Vaz | |
dc.contributor.author | Neves, Arminda | |
dc.contributor.author | Passarinha, L A | |
dc.contributor.author | Tomaz, C. T. | |
dc.date.accessioned | 2020-02-10T10:25:43Z | |
dc.date.available | 2021-05-13T00:30:13Z | |
dc.date.issued | 2018-05-13 | |
dc.description.abstract | VEGF-A and VEGF-B are proangiogenic and key regulating factors for blood vessel growth. This study aims to compare VEGF-A and VEGF-B levels in the serum and vitreous of patients with neovascular pathology versus non-neovascular pathology. Our findings showed vitreous VEGF-A and VEGF-B levels increased in patients with neovascular disease, with higher levels of VEGF-A compared to VEGF-B (p ≤ .05). In the diabetic retinopathy (DR) group, higher vitreous VEGF-A or VEGF-B were found in proliferative diabetic retinopathy (PDR) than in non-PDR. The strong correlation between VEGF-A and VEGF-B demonstrates a simultaneous pathological increase of cytokines (p < .001), suggesting besides VEGF-A, VEGF-B is another contributor to ocular pathologies involving angiogenesis. There was no correlation between vitreous and serum VEGF-A or VEGF-B; however, a correlation between vitreous (VEGF-A or VEGF-B) and macular volume (p < .05) in DR patients was found. Targeting VEGF-A and VEGF-B in macular and retinal vascular diseases, involving neovascularization, may improve treatment outcomes. | pt_PT |
dc.description.sponsorship | POCI-01-0145-FEDER-007491 | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.doi | 10.1080/08977194.2018.1477140 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.6/9160 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Taylor & Francis | pt_PT |
dc.subject | Neovascularization, Pathologic | pt_PT |
dc.subject | Retinal Diseases | pt_PT |
dc.subject | Retrospective Studies | pt_PT |
dc.subject | Vascular Endothelial Growth Factor A | pt_PT |
dc.subject | Vascular Endothelial Growth Factor B | pt_PT |
dc.subject | Vitreous Body | pt_PT |
dc.subject | ELISA | pt_PT |
dc.title | Evaluation of the growth factors VEGF-a and VEGF-B in the vitreous and serum of patients with macular and retinal vascular diseases | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/5876/UID%2FMulti%2F00709%2F2013/PT | |
oaire.citation.endPage | 57 | pt_PT |
oaire.citation.issue | 1-2 | pt_PT |
oaire.citation.startPage | 48 | pt_PT |
oaire.citation.title | Growth Factors | pt_PT |
oaire.citation.volume | 36 | pt_PT |
oaire.fundingStream | 5876 | |
person.familyName | Mesquita | |
person.familyName | Castro de Sousa | |
person.familyName | Vaz-Pereira | |
person.familyName | Paulino Passarinha | |
person.familyName | Tomaz | |
person.givenName | Joana | |
person.givenName | João Paulo | |
person.givenName | Sara | |
person.givenName | Luís António | |
person.givenName | Cândida | |
person.identifier | https://www.researchgate.net/profile/Luis_Passarinha | |
person.identifier | 2198714 | |
person.identifier.ciencia-id | D81B-D3DE-23D2 | |
person.identifier.ciencia-id | 621B-74BF-F9A7 | |
person.identifier.ciencia-id | FE13-0C44-13D1 | |
person.identifier.orcid | 0000-0003-0667-0809 | |
person.identifier.orcid | 0000-0002-0025-1841 | |
person.identifier.orcid | 0000-0001-6125-5486 | |
person.identifier.orcid | 0000-0001-6910-7576 | |
person.identifier.orcid | 0000-0002-0927-2331 | |
person.identifier.rid | P-8249-2017 | |
person.identifier.rid | F-9367-2014 | |
person.identifier.scopus-author-id | 56262249200 | |
person.identifier.scopus-author-id | 55820663800 | |
person.identifier.scopus-author-id | 12445439600 | |
person.identifier.scopus-author-id | 7004546303 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.embargofct | Copyright cedido à editora no momento da publicação | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 7441ce5b-4553-4e63-aee6-84224b05356e | |
relation.isAuthorOfPublication | b53f642a-416d-4873-a962-3c1b34306e6f | |
relation.isAuthorOfPublication | c0931476-ec68-47b4-98b0-2b1a5da85748 | |
relation.isAuthorOfPublication | a431a31c-1ae0-43e9-8d84-4e9caca2ad92 | |
relation.isAuthorOfPublication | a8b816a2-a48c-43b1-a064-2ae8aa4b9bf8 | |
relation.isAuthorOfPublication.latestForDiscovery | c0931476-ec68-47b4-98b0-2b1a5da85748 | |
relation.isProjectOfPublication | cb4688cf-40da-4197-9eb0-c55bad699ad3 | |
relation.isProjectOfPublication.latestForDiscovery | cb4688cf-40da-4197-9eb0-c55bad699ad3 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 40Growth_Factors_2018.pdf
- Size:
- 1.5 MB
- Format:
- Adobe Portable Document Format
- Description:
- Growth_Factors_2018
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: